Cannabinoid Ratio Selection
Cannabinoid ratio selection is a breeding discipline focused on intentionally developing plants that express specific proportions of cannabinoids, most commonly THC to CBD ratios. Rather than pursuing maximum single-cannabinoid content, breeders working in this category target balanced or inverted profiles—such as 1:1 THC:CBD, high-CBD low-THC, or rare cannabinoid-forward lines (CBG, CBC, CBN). This approach requires multi-generational selection, marker-assisted breeding, and careful phenotyping to stabilize desired ratios across seed runs. Cannabinoid ratio selection has expanded breeding objectives beyond potency metrics, enabling development of genetically distinct chemovars suited to specialized cultivation and research contexts.
Cannabinoid Ratio Selection strains
No strains tagged into Cannabinoid Ratio Selection yet — they'll appear here as breeders submit lineage records under this classification.
Cannabinoid ratio selection is a breeding discipline focused on intentionally developing plants that express specific proportions of cannabinoids, most commonly THC to CBD ratios. Rather than pursuing maximum single-cannabinoid content, breeders working in this category target balanced or inverted profiles—such as 1:1 THC:CBD, high-CBD low-THC, or rare cannabinoid-forward lines (CBG, CBC, CBN). This approach requires multi-generational selection, marker-assisted breeding, and careful phenotyping to stabilize desired ratios across seed runs. Cannabinoid ratio selection has expanded breeding objectives beyond potency metrics, enabling development of genetically distinct chemovars suited to specialized cultivation and research contexts.
Breeders employing cannabinoid ratio selection must test offspring chemically—via HPLC, GC-MS, or similar—to identify and stabilize target ratios before releasing seed lines. This technique is foundational to creating chemotypically diverse germplasm libraries and supporting research into minor and novel cannabinoids.
Educational reference · Cultivar metadata only · No medical claims